ClinicalTrials.Veeva

Menu

Determine the Effects of Prone Positioning and NO in COVID-19 ARDS by EIT

Fudan University logo

Fudan University

Status

Enrolling

Conditions

COVID-19
Respiratory Distress Syndrome, Adult

Treatments

Drug: NO inhalation
Behavioral: prone postion

Study type

Observational

Funder types

Other

Identifiers

NCT05715762
eit20221221

Details and patient eligibility

About

We aims to investigate the effects of prone positioning and nitric oxide inhalation in adult patients who is diagnosed with COVID-19 associated acute respiratory distress syndrome by electrical impedance tomography.

Full description

The investigators aim to investigate the effects of prone positioning and nitric oxide inhalation in adult patients who is diagnosed with COVID-19 associated acute respiratory distress syndrome by electrical impedance tomography (EIT).

The EIT assessment is performed in patients ventilated in supine position, supine position with NO inhalation for 1 hour, prone position for 1 hour, prone position for 2 hours with NO inhalation for 1 hour, prone position for 3 hours, prone position for 16 hours, re-supine position for 3 hours. Arterial blood gas (ABG) analysis results, ventilator parameters and hemodynamic parameters are also recorded at each time point.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients who have COVID-19-associated acute respiratory distress syndrome

Exclusion criteria

  • patients who refuse to participate in the study; unable to use EIT, such as open-chest surgery with chest tube placement; have contraindication for prone positioning, including pregnant, post-abdomen surgery within a week; hypercapnic respiratory failure.

Trial design

20 participants in 7 patient groups

Ventilation in supine position
Description:
Patients are ventilated in supine position.
Ventilation in supine position and NO inhalation
Description:
Patients are ventilated in supine position with NO inhalation for 1 hour.
Treatment:
Drug: NO inhalation
Ventilation in prone position for 1 hour
Description:
Patients are ventilated in prone position for 1 hour.
Treatment:
Behavioral: prone postion
Ventilation in prone position for 2 hours plus NO inhalation for 1 hour
Description:
Patients are ventilated in prone position for 1 hour followed by ventilation in prone position with NO inhalation for 1 hour.
Treatment:
Drug: NO inhalation
Behavioral: prone postion
Ventilation in prone position for 3 hours
Description:
Patients are ventilated in prone position for 1 hour followed by ventilation in prone position with NO inhalation for 1 hour. Then they are ventilated in prone position alone for 1 hour.
Treatment:
Behavioral: prone postion
Ventilation in prone position for 16 hours
Description:
Patients are ventilated in prone position for 1 hour followed by ventilation in prone position with NO inhalation for 1 hour. Then they are ventilated in prone position alone for 14 hours.
Treatment:
Behavioral: prone postion
Ventilation in re-supine position for 3 hours
Description:
Patients are ventilated in supine position for 3 hours followed by ventilation in prone position for 16 hours.

Trial contacts and locations

1

Loading...

Central trial contact

Ming Zhong, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems